查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1876567

Omega-3脂肪酸市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

Omega-3 Fatty Acids Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球 Omega-3 脂肪酸市场价值为 32 亿美元，预计到 2034 年将以 3.6% 的复合年增长率增长至 48 亿美元。

Omega-3脂肪酸市场 - IMG1

越来越多的科学研究凸显了ω-3脂肪酸的健康益处，这是推动市场成长的主要动力。目前已有超过4万篇关于EPA和DHA的同侪审查研究，其中包括数千项临床试验，证实了它们对心血管、大脑和眼睛健康的积极作用，消费者对ω-3的认知度持续提升。大众对预防性健康和营养的日益重视，推动了对ω-3补充剂的需求，尤其是那些针对心臟和认知健康的补充剂。人们对功能性食品和强化食品的广泛兴趣进一步促进了市场发展，食品和饮料生产商将ω-3成分添加到烘焙食品、乳製品和饮料等日常食品中。人们逐渐将ω-3纳入日常营养，而非仅依赖膳食补充剂，这正在拓展市场应用范围，并为各地区的长期成长前景奠定基础。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 32亿美元
预测值 48亿美元
复合年增长率 3.6%

受消费者对永续和植物来源产品的强劲需求推动，藻类来源的ω-3产品市场预计到2034年将以3.9%的复合年增长率成长。微藻养殖技术的快速发展和人们环保意识的不断增强提升了该品类的吸引力。藻油是更干净、更浓缩的EPA和DHA来源，因此只需服用少量即可，并消除了传统海洋来源ω-3产品的常见鱼腥味等问题。这项优势正助力植物来源的ω-3产品在膳食补充剂和强化食品配方领域获得更大的市场份额。

2024年，一般保健品和膳食补充剂占据了24%的市场份额，反映出消费者对omega-3产品在维持整体健康和预防慢性疾病方面的认可度很高。这些品类继续受益于零售和线上通路的高可及性，儘管不同仿製药的临床疗效仍存在差异。功能性食品和强化食品约占16%的市场份额，这得益于製造商不断进行产品创新，将omega-3添加到饮料、烘焙食品和乳製品中，以满足消费者对营养便捷食品的需求。

2024年美国ω-3脂肪酸市场规模为7.813亿美元，预计到2034年将达到11亿美元。北美市场环境成熟，消费者拥有完善的膳食补充剂消费习惯，并且对健康益处的认知度不断提高。美国是该地区市场的领头羊，占据北美约83%的市场份额，这得益于其广泛的零售分销、直销模式以及医疗专业人士的推荐。美国的监管环境保持稳定，FDA的监管以及ω-3成分的GRAS（公认安全）认证进一步增强了消费者的信心。

全球ω-3脂肪酸市场的主要参与者包括帝斯曼-菲美意（DSM-Firmenich）、巴斯夫（BASF SE）、科莱恩（Croda International）、阿克生物海洋（Aker BioMarine）、ADM（Archer Daniels Midland）、嘉吉（Cargill）、科比恩（Corbion）、欧米加製药公司（Ogam）集团。 ω-3脂肪酸市场的领导企业正积极推行策略倡议，以巩固其市场地位并拓展全球业务。许多企业正致力于永续采购，投资藻类ω-3生产，以减少对海洋资源的依赖。此外，各公司也透过先进的纯化技术提升产品品质，并优化EPA/DHA浓度水平，以满足消费者多样化的需求。策略併购和合作正帮助主要生产商拓展供应链网络，并进入新的区域市场。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

  • 产业生态系分析
    • 供应商格局
    • 利润率
    • 每个阶段的价值增加
    • 影响价值链的因素
    • 中断
  • 产业影响因素
    • 成长驱动因素
    • 产业陷阱与挑战
    • 市场机会
  • 成长潜力分析
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特的分析
  • PESTEL 分析
  • 价格趋势
    • 按地区
  • 未来市场趋势
  • 技术与创新格局
    • 当前技术趋势
    • 新兴技术
  • 专利格局
  • 贸易统计（HS编码）（註：仅提供重点国家的贸易统计资料）
    • 主要进口国
    • 主要出口国
  • 永续性和环境方面
    • 永续实践
    • 减少废弃物策略
    • 生产中的能源效率
    • 环保倡议
  • 碳足迹考量

第四章：竞争格局

  • 介绍
  • 公司市占率分析
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • 中东和非洲
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 关键进展
    • 併购
    • 合作伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场规模及预测：依产品类型划分，2021-2034年

  • 主要趋势
  • 海洋来源的ω-3
    • 鱼油
    • 浓缩鱼油
    • 磷虾油和磷脂形式
    • 其他的
  • 藻类来源的ω-3
    • 微藻油
    • 发酵法提取的EPA和DHA
  • 植物性ω-3（ALA）
    • 亚麻仁油
    • 奇亚籽油
    • 其他的
  • 处方ω-3药物
  • 浓缩和纯化形式

第六章：市场规模及预测：依应用领域划分，2021-2034年

  • 主要趋势
  • 心血管健康
    • 第一级预防产品
    • 二级预防方案
    • 血压管理
    • 预防心律不整
  • 高三酸甘油脂血症治疗
    • 严重高三酸甘油酯血症
    • 中度高三酸甘油酯血症
  • 一般健康与膳食补充剂
    • 每日营养
    • 大脑健康与认知功能
    • 眼部健康与视力支持
    • 关节健康与炎症
  • 功能性食品与强化
    • 乳製品
    • 烘焙食品和糖果
    • 饮料强化
    • 肉类和家禽
  • 婴幼儿及孕产妇营养
    • 婴儿配方奶粉应用
    • 怀孕及产后补充剂
    • 儿科营养产品
  • 动物饲料和水产养殖
    • 水产饲料
    • 宠物食品
    • 牲畜饲料

第七章：市场规模及预测：依最终用途产业划分，2021-2034年

  • 主要趋势
  • 製药业
  • 营养保健品和膳食补充品产业
  • 食品饮料业
  • 动物饲料业

第八章：市场规模及预测：依地区划分，2021-2034年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第九章：公司简介

  • DSM-Firmenich
  • BASF SE
  • Croda International
  • Aker BioMarine
  • Archer Daniels Midland
  • Cargill
  • Corbion
  • Omega Protein Corporation
  • Epax
  • KD Pharma Group
  • Polaris Nutritional Lipids
  • Solutex
  • Veramaris
  • Yield10 Bioscience
  • AlgaeCytes
  • Fermentalg
  • Qualitas Health
简介目录
Product Code: 15126

The Global Omega-3 Fatty Acids Market was valued at USD 3.2 billion in 2024 and is estimated to grow at a CAGR of 3.6% to reach USD 4.8 billion by 2034.

Omega-3 Fatty Acids Market - IMG1

The expanding body of scientific research highlighting the health advantages of omega-3 fatty acids is a major driver of market growth. With over 40,000 peer-reviewed studies on EPA and DHA, including thousands of clinical trials confirming their positive effects on cardiovascular, brain, and eye health, consumer awareness continues to rise. Increasing public awareness of preventive health and nutrition is fueling demand for omega-3 supplements, particularly those targeting heart and cognitive health. The broader interest in functional and fortified food products further propels the market, as food and beverage manufacturers integrate omega-3 ingredients into everyday items such as baked goods, dairy, and beverages. The move toward incorporating omega-3 into daily nutrition rather than relying solely on dietary supplements is expanding market applications and supporting long-term growth prospects across regions.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$3.2 Billion
Forecast Value$4.8 Billion
CAGR3.6%

The algal-derived omega-3 segment is expected to grow at a CAGR of 3.9% through 2034, driven by strong consumer interest in sustainable and plant-based sources. The rapid advancement of microalgae cultivation technologies and increasing awareness of environmental concerns have boosted this category's appeal. Algal oil offers a cleaner and more concentrated source of EPA and DHA, enabling smaller doses and eliminating issues such as the fishy odor often associated with traditional marine-based omega-3 products. This advantage is helping plant-based alternatives gain greater traction in both dietary supplements and fortified food formulations.

In 2024, the general wellness and dietary supplements held a 24% share, reflecting strong consumer acceptance of omega-3 products for maintaining overall health and preventing chronic conditions. These categories continue to benefit from high accessibility through retail and online channels, although the clinical efficacy among different generic products remains variable. Functional foods and fortification represented around 16% of the market, supported by ongoing product innovation as manufacturers incorporate omega-3 into beverages, bakery items, and dairy products to meet consumer demand for nutritious and convenient options.

United States Omega-3 Fatty Acids Market was valued at USD 781.3 million in 2024 and is projected to reach USD 1.1 billion by 2034. North America represents a mature market environment, characterized by well-established supplement consumption habits and heightened consumer awareness of health and wellness benefits. The United States leads the regional market, holding around 83% of North American sales, supported by extensive retail distribution, direct-to-consumer marketing, and medical professional recommendations. The regulatory landscape in the U.S. remains stable, and consumer confidence is reinforced through FDA oversight and GRAS (Generally Recognized as Safe) certifications for omega-3 ingredients.

Key participants in the Global Omega-3 Fatty Acids Market include DSM-Firmenich, BASF SE, Croda International, Aker BioMarine, Archer Daniels Midland, Cargill, Corbion, Omega Protein Corporation, Epax, and KD Pharma Group. Leading players in the Omega-3 Fatty Acids Market are pursuing strategic initiatives to strengthen their market positions and expand global reach. Many are focusing on sustainable sourcing by investing in algal-based omega-3 production to reduce dependence on marine resources. Companies are also enhancing product quality through advanced purification technologies and optimizing EPA/DHA concentration levels to meet diverse consumer needs. Strategic mergers, acquisitions, and partnerships are helping major manufacturers expand supply networks and enter new regional markets.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Product Type
    • 2.2.2 Application
    • 2.2.3 End Use Industry
  • 2.3 TAM analysis, 2025-2034
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
  • 3.8 Future market trends
  • 3.9 Technology and innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent landscape
  • 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint considerations

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East & Africa
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Size and Forecast, By Product Type, 2021-2034 (USD Billion, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Marine-derived omega-3
    • 5.2.1 Fish oil
    • 5.2.2 Concentrated fish oil
    • 5.2.3 Krill oil & phospholipid forms
    • 5.2.4 Others
  • 5.3 Algal-derived omega-3
    • 5.3.1 Microalgae oil
    • 5.3.2 Fermentation-derived EPA & DHA
  • 5.4 Plant-based omega-3 (ALA)
    • 5.4.1 Flaxseed oil
    • 5.4.2 Chia seed oil
    • 5.4.3 Others
  • 5.5 Prescription omega-3 drugs
  • 5.6 Concentrated & purified forms

Chapter 6 Market Size and Forecast, By Application, 2021-2034 (USD Billion, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Cardiovascular health
    • 6.2.1 Primary prevention products
    • 6.2.2 Secondary prevention formulations
    • 6.2.3 Blood pressure management
    • 6.2.4 Arrhythmia prevention
  • 6.3 Hypertriglyceridemia treatment
    • 6.3.1 Severe hypertriglyceridemia
    • 6.3.2 Moderate hypertriglyceridemia
  • 6.4 General wellness & dietary supplements
    • 6.4.1 Daily nutrition
    • 6.4.2 Brain health & cognitive function
    • 6.4.3 Eye health & vision support
    • 6.4.4 Joint health & inflammation
  • 6.5 Functional foods & fortification
    • 6.5.1 Dairy product
    • 6.5.2 Bakery & confectionery
    • 6.5.3 Beverage fortification
    • 6.5.4 Meat & poultry
  • 6.6 Infant & maternal nutrition
    • 6.6.1 Infant formula applications
    • 6.6.2 Prenatal & postnatal supplements
    • 6.6.3 Pediatric nutrition products
  • 6.7 Animal feed & aquaculture
    • 6.7.1 Aquaculture feed
    • 6.7.2 Pet food
    • 6.7.3 Livestock feed

Chapter 7 Market Size and Forecast, By End Use Industry, 2021-2034 (USD Billion, Kilo Tons)

  • 7.1 Key trends
  • 7.2 Pharmaceutical industry
  • 7.3 Nutraceutical & dietary supplement industry
  • 7.4 Food & beverage industry
  • 7.5 Animal feed industry

Chapter 8 Market Size and Forecast, By Region, 2021-2034 (USD Billion, Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 UK
    • 8.3.2 Germany
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 DSM-Firmenich
  • 9.2 BASF SE
  • 9.3 Croda International
  • 9.4 Aker BioMarine
  • 9.5 Archer Daniels Midland
  • 9.6 Cargill
  • 9.7 Corbion
  • 9.8 Omega Protein Corporation
  • 9.9 Epax
  • 9.10 KD Pharma Group
  • 9.11 Polaris Nutritional Lipids
  • 9.12 Solutex
  • 9.13 Veramaris
  • 9.14 Yield10 Bioscience
  • 9.15 AlgaeCytes
  • 9.16 Fermentalg
  • 9.17 Qualitas Health